This is a US news story, published by CIDRAP, that relates primarily to RSV news.
For more US news, you can click here:
more US newsFor more biology news, you can click here:
more biology newsFor more news from CIDRAP, you can click here:
more news from CIDRAPOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
RSV Hospitalization. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest RSV Hospitalization Surveillance Network news, severe RSV disease news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
respiratory syncytial virusCIDRAP
•
88% Informative
RSV is the leading cause of hospitalization for US infants, but it also causes severe and serious illnesses in adults, especially those 75 and older.
The 2017-2018 season carried the highest burden of severe illness, with 8,620 in-hospital deaths.
The 2023-2024 season marked the first season an RSV vaccine was available in the United States for adults over 60 at risk for severe outcomes.
VR Score
96
Informative language
99
Neutral language
77
Article tone
formal
Language
English
Language complexity
64
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
1
Source diversity
1
Affiliate links
no affiliate links